We are live on ! Find out more
CC

Commodore Capital Portfolio holdings

AUM $1.73B
1-Year Est. Return 298.96%
This Fund
S&P 500
This Quarter Est. Return
+48.36%
1 Year Est. Return
+298.96%
3 Year Est. Return
+2,048.53%
5 Year Est. Return
+6,668.48%
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$164M
Cap. Flow %
89.08%
Top 10 Hldgs %
54.84%
Holding
28
New
28
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CCCC icon
C4 Therapeutics
CCCC
+$14M
2
TRIL
Trillium Therapeutics Inc.
TRIL
+$12.3M
3
CBAY
Cymabay Therapeutics
CBAY
+$11.2M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$10.7M
5
KRON
Kronos Bio
KRON
+$9.38M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 91.66%
2 Financials 1.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGMS
26
Bio Green Med Solution Inc
BGMS
$5.05M
$2.07M 1.12%
+74
New +$1.13M
TPST icon
27
Tempest Therapeutics
TPST
$14.8M
$1.98M 1.08%
+4,744
New +$1.64M
SNCE
28
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.07M 0.58%
+5,000
New +$1.04M
1
2

Similar funds

RIA
Regal Investment Advisors Kentwood, Michigan $1.73B AUM 17.74% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
ESBC
E.S. Barr & Co Lexington, Kentucky $1.72B AUM 12.69% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $1.72B AUM 48.78% 1-Year Est. Return
WJA
Willis Johnson & Associates Houston, Texas $1.72B AUM 16.93% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Commodore Capital's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Commodore Capital, which disclosed 28 positions worth $184M. Its ten largest holdings account for 55% of the portfolio.

Its largest position is C4 Therapeutics: 481,094 shares worth $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, followed by Financials.

  • Commodore Capital's largest Q4 2020 buy was C4 Therapeutics: 481,094 shares worth $15.9M.
  • Commodore Capital's ten largest holdings make up 55% of its $184M portfolio in Q4 2020.
  • Commodore Capital disclosed 28 positions in Q4 2020, its first 13F filing on record.

Based on Commodore Capital's 13F filing for Q4 2020, filed 16 Feb 2021.